By Amber Deter The AbCellera IPO is right around the corner. People are excited about the news that this company is helping to produce a coronavirus treatment. And investors are looking for AbCellera stock to hit the market.
But should you invest in AbCellera? Here’s what we know…
AbCellera IPO: The Business
CEO Carl Hansen and Véronique Lecault co-founded AbCellera Biologics in 2012. Based in Vancouver, AbCellera is a biotech firm focused on antibody therapeutics for common diseases and pandemics. The company believes the future of health is in the advancement of technology. AbCellera uses an artificial-intelligence (AI) powered platform to search and analyze a database …read more
